Skip to search boxSkip to navigationSkip to main content

Escherichia coli st131 clones harbouring AGGR and AAF/V fimbriae causing bacteremia in Mozambican children: Emergence of new variant of FIMH27 subclone

  • Inácio Mandomando
    ,
  • Delfino Vubil
    ,
  • Nadia Boisen
    ,
  • Llorenç Quintó
    ,
  • ,
  • Betuel Sigaúque
  • Centro de Investigação em Saúde da Manhiça (CISM)
    ,
  • Ministério da Saúde
    ,
  • Statens Serum Institut
    ,
  • Hospital Clínic – Universitat de Barcelona
    ,
  • ,
  • Universidad Continental, Huancayo
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Article number

e0008274

Pages from-to (Number of pages)

Pages 1-21 (21 pages)

Journal (Volume, Issue Number)

PLoS Neglected Tropical Diseases (Volume 14, Issue 5)

Publication milestones

  • Published - 05/2020

Publication status

Published - 05/2020

ISSN

1935-2727

Publication IDs

  • Scopus: 85084695127
  • PubMed: 32357189

Abstract

Multidrug-resistant Escherichia coli ST131 fimH30 responsible for extra-intestinal pathogenic (ExPEC) infections is globally distributed. However, the occurrence of a subclone fimH27 of ST131 harboring both ExPEC and enteroaggregative E. coli (EAEC) related genes and belonging to commonly reported O25:H4 and other serotypes causing bacter-emia in African children remain unknown. We characterized 325 E. coli isolates causing bacteremia in Mozambican children between 2001 and 2014 by conventional multiplex poly-merase chain reaction and whole genome sequencing. Incidence rate of EAEC bacteremia was calculated among cases from the demographic surveillance study area. Approximately 17.5% (57/325) of isolates were EAEC, yielding an incidence rate of 45.3 episodes/105 chil-dren-years-at-risk among infants; and 44 of isolates were sequenced. 72.7% (32/44) of sequenced strains contained simultaneously genes associated with ExPEC (iutA, fyuA and traT); 88.6% (39/44) harbored the aggregative adherence fimbriae type V variant (AAF/V). Sequence type ST-131 accounted for 84.1% (37/44), predominantly belonging to serotype O25:H4 (59% of the 37); 95.6% (35/44) harbored fimH27. Approximately 15% (6/41) of the children died, and five of the six yielded ST131 strains (83.3%) mostly (60%; 3/5) due to serotypes other than O25:H4. We report the emergence of a new subclone of ST-131 E. coli strains belonging to O25:H4 and other serotypes harboring both ExPEC and EAEC virulence genes, including agg5A, associated with poor outcome in bacteremic Mozambican children, suggesting the need for prompt recognition for appropriate management.

Funding Details

CISM receives core funding from “Agencia Española de Cooperacion Internacional para el Desarollo (AECID)”. Joaquim Ruiz had a fellowship from the program I3SNS, of the ISCIII (grant number: CES11/012). Jordi Vila is supporteby the Spanish Network for the Research in Infectious Diseases (REIPI RD16/0010). Nadia Boisen was funded by the Independent Research Fund Denmark (grant number: DFF1333-00156). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank the CISM and MDH staff for collecting and processing data; and the District Health Authorities for their collaboration in the research activities on-going in the Man-hiça district. Special thanks for the CISM Bacteriology and Molecular Biology laboratory technicians for sample processing. Special thanks for Augusto Messa Junior for revision of the manuscript. We are indebted to the children and mothers participating in the study.
FundersFunding numbers
CISM
-
District Health Authorities
-
Spanish Network for the Research in Infectious Diseases
REIPI RD16/0010
ISCIII
CES11/012
AECID
-
DFF
DFF1333-00156

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Captures
64
Citations
25

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well